Page last updated: 2024-09-04

moxifloxacin and pradigastat

moxifloxacin has been researched along with pradigastat in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (pradigastat)	Trials (pradigastat)	Recent Studies (post-2010) (pradigastat)
3,157	552	1,690	24	13	24

Protein Interaction Comparison

Protein	Taxonomy	moxifloxacin (IC50)	pradigastat (IC50)
Diacylglycerol O-acyltransferase 1	Homo sapiens (human)		0.0605

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Crissey, A; Kulmatycki, K; Majumdar, T; Meyers, CD; Movva, A; Neelakantham, S; Noe, A; Salunke, A	1

Trials

1 trial(s) available for moxifloxacin and pradigastat

Article	Year
Effect of Pradigastat, a Diacylglycerol Acyltransferase 1 Inhibitor, on the QTcF Interval in Humans. Clinical pharmacology in drug development, 2016, Volume: 5, Issue:6 Topics: Acetates; Adolescent; Adult; Aminopyridines; Body Mass Index; Diacylglycerol O-Acyltransferase; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Enzyme Inhibitors; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Hyperlipoproteinemia Type I; Long QT Syndrome; Male; Moxifloxacin; Young Adult	2016

Article

Year

Effect of Pradigastat, a Diacylglycerol Acyltransferase 1 Inhibitor, on the QTcF Interval in Humans.

Clinical pharmacology in drug development, 2016, Volume: 5, Issue:6

Topics: Acetates; Adolescent; Adult; Aminopyridines; Body Mass Index; Diacylglycerol O-Acyltransferase; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Enzyme Inhibitors; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Hyperlipoproteinemia Type I; Long QT Syndrome; Male; Moxifloxacin; Young Adult

2016